Pharmaceuticals, Biotechnology and Life Sciences
WILMINGTON, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24CRL&src=ctag" target="_blank"gt;$CRLlt;/agt; lt;a href="https://twitter.com/hashtag/earnings?src=hash" target="_blank"gt;#earningslt;/agt;–Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2019 financial results…
New machine learning models and novel analysis methods address customer requests LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq:SLP), the leading provider…
Report Ranks Digital Performance of 88 U.S. Pharmaceutical Brands; 75 Percent Rank Above Average Despite Unprecedented Scrutiny and Regulation STAMFORD,…
SAN FRANCISCO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/DNA?src=hash" target="_blank"gt;#DNAlt;/agt;–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality…
Leading gene therapy company announces $235 million investment to accelerate growth RESEARCH TRIANGLE PARK, N.C.& FORT WORTH, Texas & SAN…
LEXINGTON, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24CNCE&src=ctag" target="_blank"gt;$CNCElt;/agt; lt;a href="https://twitter.com/hashtag/CNCE?src=hash" target="_blank"gt;#CNCElt;/agt;–Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that interim clinical data from its…
DUBLIN–(BUSINESS WIRE)–The “In vivo CRO Market Size, Share & Trends Analysis Report By Product Type, By GLP Type, By Indication…
DUBLIN–(BUSINESS WIRE)–The “Angiotensin Converting Enzyme (ACE) Inhibitor -Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Angiotensin Converting…
Mice fed high-fat diet and treated with Gel-B (GS300 prototype) hydrogel were protected against the development of fatty liver and…
— New Proof-of-Concept Data for Combination of Investigational FXR Agonist Cilofexor and ACC Inhibitor Firsocostat in NASH — FOSTER CITY,…